MIT xPRO's Drug and Medical Device Development: A Strategic Approach is an 8-week online course offered by MIT xPRO in partnership with Emeritus. It is designed for individuals and companies operating in the health product industry or those looking to enter the field. It caters to engineers, executives, scientists, quality assurance and regulatory affairs professionals, entrepreneurs, and professionals transitioning into the healthcare industry. The course provides a comprehensive understanding of the complex process of bringing medical devices and pharmaceuticals to market.
Participants will learn about the strategic planning and development process, from initial planning to product commercialization. They will explore the interplay between strategy and development, frameworks for assessing risks and benefits, regulatory requirements in the U.S. market, and the process of achieving approval. The course also facilitates the development of professional networks for career advancement, industry partnerships, or strategic alliances.
The program highlights the significant opportunities in the medical technology market, with estimated volumes of medical devices reaching $435.7 billion in 2022 and a projected market volume of $644.2 billion by 2026.
The course consists of seven modules covering various aspects of medical product development. Topics include strategy, reimbursement, proof of concept, intellectual property, clinical trials, quality systems, diagnostics, biomarkers, wearable devices, software regulations, drug discovery, toxicity, formulation, stability, medical devices, parenteral products, and biologics. Each module provides a comprehensive overview and explores the complexities involved in developing medical products.
By completing the MIT xPRO "Drug and Medical Device Development: A Strategic Approach" course, participants will gain the knowledge and skills necessary to navigate the intricacies of the healthcare industry, develop innovative medical devices and pharmaceuticals, and make informed strategic decisions throughout the product development process.
MIT xPRO's Drug and Medical Device Development: A Strategic Approach costs $3,550.
You may find more information about the course on its About Page: Drug and Medical Device Development: A Strategic Approach. For further questions, please contact Emeritus Support directly via info@emeritus.org.